Ryan Lynch, See Remarks at CRESCENT BIOPHARMA, INC. (CBIO), sold 240 shares at $17.90 ($4K) on 2026-09-16, disclosed to the SEC on 2026-09-18.
Scheduled sale ($4k) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |